Key facts
- DIMENSIONAL FUND ADVISORS LP filed SCHEDULE 13G/A for Supernus Pharmaceuticals Inc Common Stock (SUPN).
- Disclosed ownership: 4.7%.
- Date of event: 31 Dec 2025.
DIMENSIONAL FUND ADVISORS LP - 31 Dec 2025 SCHEDULE 13G/A Report for Supernus Pharmaceuticals Inc Common Stock (SUPN)
- Filing manager
- DIMENSIONAL FUND ADVISORS LP
- Reporting owner
- Dimensional Fund Advisors LP
- Disclosed shares
- 2,712,341 shares
- Ownership percentage
- 4.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Jan 2026, 13:21:12 UTC
- Event date
- 31 Dec 2025
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
DIMENSIONAL FUND ADVISORS LP disclosed 4.7% ownership in Supernus Pharmaceuticals Inc Common Stock (SUPN) on 31 Dec 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Jan 2026, 13:21.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Dimensional Fund Advisors LP | 4.7% | 2,712,341 | 2,650,157 | 0 | Selwyn Notelovitz | Global Chief Compliance Officer |
CIK / CUSIP context first